Skip to main content
Research Center for Molecular Medicine of the Austrian Academy of Sciences
CD Laboratory for Chemical Epigenetics and Antiinfectives
FFG Bridge "ImmunoDegraders"
FWF DK W 1212-B21 "IAI"
FWF International I4768 "Resetting the Epigenetic Status of the DM1Locus"
FWF 1000 Ideas TAI289 "The Human Mini-Cell"
FWF SFB F 4711-B20 "Myeloproliferative Neoplasms"
FWF SFB F 6102-B21 "Chromatin Landscapes"
FWF SFB F 5402-B21 "Microparticles as modulators of inflammation and thrombosis"
FWF SFB F 4701-B20 "Myeloproliferative Neoplasms"
FWF SFB F 7002-B21 "HDACs as regulators of T cell-mediated immunity in health and disease"
FWF SFB F 7909-B "Chemical probing and functional characterization of the E3 substrate receptor DCAF15"
FWF Stand-Alone P 30047-B30
FWF Stand-Alone P 30271 - B28
FWF Stand-Alone P 32125-B
FWF Stand-Alone P 31690-B28
FWF Stand-Alone P 30041-B26
FWF Stand-Alone P 31113-B30
OeAW New Frontier Group 2013
OeAW NFRI 2015
OeAW Innovationsfonds "KRAScondensate"
WWTF Vienna Research Group Leader
WWTF LS16-034 "PHARMACOSCOPY"
WWTF LS16-060 "PrecisePID"
WWTF LS17-059 "3C - Cellular Color Chart"
WWTF LS18 - 058 "Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice"
WWTF LS18 - 049 "Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy"
WWTF NXT19-008 "DataDiVR"
FFG Bridge Program 2019
Duration 2019 - 2022
Georg Winter's Group
Innovating Strategies to prompt anti-cancer immunity via targeted protein degradation